Gefapixant Citrate Drug Interaction Studies

Gefapixant Citrate (Gefapixant Citrate), as a drug used to treat chronic cough, mainly exerts its antitussive effect by inhibiting P2X3 receptors. It is one of the few innovative drugs currently on the market for chronic cough. Its unique mechanism of action gives it significant advantages in relieving cough. However, like other medications, the use of Gemfapixen may involve certain drug interactions, especially when used in combination with other medications.

Drug interaction refers to when two or more drugs work together in the body, which may cause the drug's efficacy to be enhanced, weakened, or cause side effects. For gemfapixin, interaction studies have focused primarily on drugs related to metabolism, especially those metabolized by the liver. The metabolic pathway of gemfapixin involves the cytochrome P450 enzyme system of the liver. Therefore, the use of drugs related to these enzymes may affect the drug concentration or efficacy of gemfapixin.

Based on available research data, there may be interactions between Gemfapixin and some commonly used drugs (such as antifungals, antiviral drugs, etc.). For example, concomitant use of gemfapixin with a strong CYP3A4 inhibitor may increase the concentration of gemfapixin in the body, thereby increasing the risk of side effects. On the contrary, the efficacy of gemfapixin may be reduced when using CYP3A4 inducers, because these drugs will accelerate the metabolism of gemfapixin and reduce its concentration in the body.

In addition, Gemfapixin may interact with the pharmacokinetics of other drugs, particularly those involving drug absorption, distribution, metabolism, and excretion. For example, certain drugs may affect the pH of the gastrointestinal tract or the rate of gastric emptying, thereby altering the absorption of Gemfapixen. It is important to note that not all patients will experience these interactions, so physicians should individualize treatment based on the patient's specific situation when using gemfapixin.

Reference materials:https://synapse.patsnap.com